Search Results 71-80 of 687 for ✅옵치핵 [핵체리.COM] 옵치핵판매 옵치핵구매 옵치핵파는곳✅

  1. A Study of the Safety and Effectiveness of INC280 Alone and in Combination with Erlotinib, When Compared to Chemotherapy in Advanced or Metastatic Non-Small Cell Lung Cancer Patients with EGFR Mutation and Amplified cMET - Mayo Clinic

    A Study of the Safety and Effectiveness of INC280 Alone and in Combination with Erlotinib, When Compared to Chemotherapy in Advanced or Metastatic Non-Small ...

  2. Study of ASTX727 vs IV Decitabine in MDS and CMML - Mayo Clinic

    After completion of PK studies during the first 2 treatment cycles, subjects will continue to receive treatment with ASTX727 from Cycle 3 onward (in 28-day ...

  3. Ensartinib (oral route) - Side effects & dosage - Mayo Clinic

    Ensartinib is used to treat non-small cell lung cancer (NSCLC) that has spread in patients who have not received other medicines (eg, ALK-inhibitors) and whose ...

  4. A Study of Disease Prediction for NOTCH3 - Mayo Clinic

    About this study. The purpose of this study is to assess NOTCH3-SVD disease progression and develop a disease prediction model using the NOTCH3-SVD staging ...

  5. A Study of XmAb ®18087 in Subjects With NET and GIST - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  6. An Extension Study for Participants in LIQ861 Trials to Evaluate the Long-term Safety of Dry Powder Inhalation of Treprostinil - Mayo Clinic

    The primary objective of this study is to evaluate the long-term safety of LIQ861 in patients with pulmonary arterial hypertension (PAH). Participation ...

  7. Study of Orally Administered AG-120 in Subjects with Advanced Hematologic Malignancies with an IDH1 Mutation - Mayo Clinic

    About this study. The purpose of this Phase I, multicenter study is to evaluate the safety, pharmacokinetics, pharmacodynamics and clinical activity of ...

  8. A Study of ONO-7475 in Patients With Acute Leukemias - Mayo Clinic

    About this study. The purpose of this study is to assess the safety and tolerability of ONO-7475 monotherapy in patients with relapsed or refractory acute ...

  9. A Study to Evaluate the Safety and Tolerability of DCC-2618 in Patients with Advanced Malignancies - Mayo Clinic

    This is a Phase 1, open-label, first-in-human (FIH) dose-escalation study designed to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics ...

  10. A Multicenter Study Assessing the Efficacy and Safety of STN1010904 Ophthalmic Suspension 0.03% and 0.1% Compared With Vehicle in Subjects With Fuchs Endothelial Corneal Dystrophy (FECD) - Mayo Clinic

    The purpose of this study is to assess the effectiveness and safety of STN1010904 ophthalmic suspension (0.03%, and 0.1 %), twice daily dosing, when compared to ...